Newsfeeds - Spark Newswire

1 minute read

News

Exact Sciences Shares See Volume, Traders Circulate UnitedHealthCare Report Highlighting Updated Preventive Care Services Policy Lowered Age For Colorectal Cancer Screening From 50-75 To 45-75; BZ Note: Exact Sciences Has Cologuard Screening Service

Today, 4:16 PM

https://www.uhcprovider.com/content/dam/provider/docs/public/policies/index/commercial/preventive-care-services-10012021.pdf

EXAS

1 minute read

Cathie Wood’s ARK Invest Posts Fund Purchases For Wednesday, Aug. 18, 2021: PATH, PLTR, Z, RPTX, SURF, QSI, VCYT, PFE, NVTA, ZY, MASS, EXAS, DYNS, CRSP, SMFR, TSP, SRNG, SGFY, NTLA, BEAM, FATE, EDIT, AVAV, BLDE, KMTUY, MKFG, CND, GENI, KVSB, LPSN

By Michael Horton

Today, 4:16 PM

UiPath (PATH) - 80,400 Shares Palantir Technologies (PLTR) - 93,189 Zillow Group (Z) - 21,507 Repare Therapeutics (RPTX) - 3,791 Surface Oncology (SURF) - 41,741 Quantum-Si (QSI) - 130,116 Veracyte (VCYT) -

AVAV

1 minute read

Cathie Wood’s ARK Invest Posts Fund Purchases For Tuesday, Aug. 17, 2021: PLTR, Z, RPTX, VCYT, QSI, ZY, NTLA, MASS, EDIT, DYNS, CRSP, BLI, SMFR, FATE, EXAS, SGFY, BEAM, NVTA, AVAV, MKFG, BLDE, KMTUY, RBLX, LPSN, KVSB, CND

By Michael Horton

Today, 4:16 PM

Palantir Technologies (PLTR) - 476,114 Shares Zillow Group (Z) - 2,800 Repare Therapeutics (RPTX) - 8,967 Veracyte (VCYT) - 40,152 Quantum-Si (QSI) - 163,972 Zymergen (ZY) - 136,853 Intellia Therapeutics (NTLA) -

AVAV

2 minute read

Global
News

Exact Sciences Receives Regulatory Approval For The Oncotype DX Breast Recurrence Score Program In Japan

By Benzinga Newsdesk

Today, 4:16 PM

Exact Sciences Corp. (NASDAQ:EXAS) today announced that Japan's Ministry of Health, Labor and Welfare (MHLW) has approved the Oncotype DX Breast Recurrence Score® Program. The test helps guide chemotherapy

EXAS

2 minute read

Movers

Unusual Options Activity Insight: Exact Sciences

By Benzinga Insights

Today, 4:16 PM

Exact Sciences (NASDAQ:EXAS) shares experienced unusual options activity on Friday. The stock price moved down to $93.95 following the option alert.

EXAS

1 minute read

Invitae Corp. Shares Up 3%; Bloomberg Reported Late Friday ‘Exact Sciences Said to Approach Invitae About Merger’; Exact Sciences Shares Down ~1%

By Benzinga Newsdesk

Today, 4:16 PM

https://www.bloomberg.com/news/articles/2021-08-06/exact-sciences-said-to-approach-invitae-about-potential-merger

EXAS

2 minute read

Movers

Unusual Options Activity Insight: Exact Sciences

By Benzinga Insights

Today, 4:16 PM

On Tuesday, shares of Exact Sciences (NASDAQ:EXAS) saw unusual options activity. After the option alert, the stock price moved down to $103.14.

EXAS

1 minute read

Canaccord Genuity Maintains Buy on Exact Sciences, Lowers Price Target to $160

By Benzinga Newsdesk

Today, 4:16 PM

Canaccord Genuity analyst Kyle Mikson maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $185 to $160.

EXAS

1 minute read

Oppenheimer Maintains Outperform on Exact Sciences, Lowers Price Target to $155

By Benzinga Newsdesk

Today, 4:16 PM

Oppenheimer analyst Kevin DeGeeter maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target from $161 to $155.

EXAS

1 minute read

10 Stocks Moving In Wednesday’s After-Hours Session

By Tyree Gorges

Today, 4:16 PM

Gainers Qualcomm (NASDAQ: QCOM) shares are trading higher after the company reported better-than-expected Q3 EPS and sales results and issued Q4 EPS guidance above estimates.

BCOV